PetVivo Holdings, Inc. (PETV)
USD 0.63
(0.0%)
USD 0.63
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -10.95 Million USD | -25.9% |
| 2023 | -8.7 Million USD | -76.09% |
| 2022 | -4.94 Million USD | -31.73% |
| 2021 | -3.75 Million USD | -77.38% |
| 2020 | -2.11 Million USD | 55.55% |
| 2019 | -4.75 Million USD | -103.55% |
| 2018 | -2.33 Million USD | 84.95% |
| 2017 | -15.53 Million USD | -325.32% |
| 2016 | -3.65 Million USD | -133.24% |
| 2015 | -1.56 Million USD | 95.77% |
| 2014 | -36.99 Million USD | -42810.07% |
| 2013 | -86.21 Thousand USD | 16.0% |
| 2012 | -102.63 Thousand USD | 61.04% |
| 2011 | -263.44 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -10.95 Million USD | -25.9% |
| 2024 Q1 | -2.89 Million USD | -24.24% |
| 2024 Q2 | -3.66 Million USD | -26.53% |
| 2024 Q4 | -2.65 Million USD | -51.48% |
| 2024 Q3 | -1.74 Million USD | 52.21% |
| 2023 Q4 | -2.32 Million USD | -1.07% |
| 2023 Q3 | -2.3 Million USD | -9.96% |
| 2023 Q2 | -2.09 Million USD | -6.7% |
| 2023 Q1 | -1.96 Million USD | -10.56% |
| 2023 FY | -8.7 Million USD | -76.09% |
| 2022 Q2 | -1.1 Million USD | -125.32% |
| 2022 FY | -4.94 Million USD | -31.73% |
| 2022 Q1 | -490.62 Thousand USD | -51.89% |
| 2022 Q3 | -1.64 Million USD | -48.55% |
| 2022 Q4 | -1.77 Million USD | -8.18% |
| 2021 Q2 | -1.34 Million USD | -65.6% |
| 2021 Q1 | -814 Thousand USD | -59.15% |
| 2021 FY | -3.75 Million USD | -77.38% |
| 2021 Q3 | -1.03 Million USD | 23.02% |
| 2021 Q4 | -323.01 Thousand USD | 68.87% |
| 2020 FY | -2.11 Million USD | 55.55% |
| 2020 Q1 | -500.88 Thousand USD | 61.39% |
| 2020 Q2 | -519.17 Thousand USD | -3.65% |
| 2020 Q3 | -551.19 Thousand USD | -6.17% |
| 2020 Q4 | -511.48 Thousand USD | 7.2% |
| 2019 Q1 | -2.09 Million USD | -119.1% |
| 2019 Q4 | -1.29 Million USD | -109.27% |
| 2019 Q3 | -619.94 Thousand USD | 16.32% |
| 2019 Q2 | -740.88 Thousand USD | 64.71% |
| 2019 FY | -4.75 Million USD | -103.55% |
| 2018 FY | -2.33 Million USD | 84.95% |
| 2018 Q4 | -958.28 Thousand USD | -72.18% |
| 2018 Q3 | -556.56 Thousand USD | -73.14% |
| 2018 Q1 | -501.03 Thousand USD | -13.94% |
| 2018 Q2 | -321.45 Thousand USD | 35.84% |
| 2017 FY | -15.53 Million USD | -325.32% |
| 2017 Q1 | -331.34 Thousand USD | 77.13% |
| 2017 Q4 | -439.74 Thousand USD | -55.94% |
| 2017 Q3 | -282 Thousand USD | 98.05% |
| 2017 Q2 | -14.47 Million USD | -4269.57% |
| 2016 Q1 | -1.37 Million USD | -109.73% |
| 2016 FY | -3.65 Million USD | -133.24% |
| 2016 Q4 | -1.44 Million USD | -269.69% |
| 2016 Q3 | -391.93 Thousand USD | 10.27% |
| 2016 Q2 | -436.8 Thousand USD | 68.21% |
| 2015 Q2 | 263.2 Thousand USD | 129.73% |
| 2015 Q1 | -885.19 Thousand USD | -209.11% |
| 2015 FY | -1.56 Million USD | 95.77% |
| 2015 Q3 | -15.06 Million USD | -5825.5% |
| 2015 Q4 | 14.12 Million USD | 193.74% |
| 2014 Q4 | 811.26 Thousand USD | 754.62% |
| 2014 Q3 | 94.92 Thousand USD | 110.69% |
| 2014 Q2 | -887.77 Thousand USD | -4720.4% |
| 2014 FY | -36.99 Million USD | -42810.07% |
| 2014 Q1 | -18.41 Thousand USD | -19.91% |
| 2013 Q1 | -23.73 Thousand USD | 46.15% |
| 2013 Q2 | -25.48 Thousand USD | -7.39% |
| 2013 Q3 | -21.62 Thousand USD | 15.14% |
| 2013 Q4 | -15.35 Thousand USD | 28.99% |
| 2013 FY | -86.21 Thousand USD | 16.0% |
| 2012 Q3 | -23.59 Thousand USD | -67.02% |
| 2012 Q2 | -14.12 Thousand USD | 32.24% |
| 2012 Q1 | -20.84 Thousand USD | -45.58% |
| 2012 FY | -102.63 Thousand USD | 61.04% |
| 2012 Q4 | -44.07 Thousand USD | -86.8% |
| 2011 FY | -263.44 Thousand USD | 0.0% |
| 2011 Q1 | -170 Thousand USD | 0.0% |
| 2011 Q2 | -41.07 Thousand USD | 75.84% |
| 2011 Q3 | -35.75 Thousand USD | 12.94% |
| 2011 Q4 | -14.32 Thousand USD | 59.95% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 86.585% |
| Cerus Corporation | -37.48 Million USD | 70.777% |
| OrthoPediatrics Corp. | -20.97 Million USD | 47.767% |
| Talis Biomedical Corporation | -62 Million USD | 82.332% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 19.346% |
| Inogen, Inc. | -102.44 Million USD | 89.307% |
| Spectral AI, Inc. | -20.85 Million USD | 47.467% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 81.974% |
| CVRx, Inc. | -41.19 Million USD | 73.409% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1811.241% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -23.789% |
| Orthofix Medical Inc. | -151.39 Million USD | 92.764% |
| Venus Concept Inc. | -37.25 Million USD | 70.59% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 82.221% |
| Bioventus Inc. | -156.23 Million USD | 92.988% |
| BrainsWay Ltd. | -4.19 Million USD | -161.027% |
| Envoy Medical, Inc. | -29.9 Million USD | 63.37% |
| electroCore, Inc. | -18.83 Million USD | 41.832% |
| IceCure Medical Ltd | -14.65 Million USD | 25.23% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 79.199% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 20.297% |
| MaxCyte, Inc. | -37.92 Million USD | 71.112% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 7.624% |
| Nexalin Technology, Inc. | -4.64 Million USD | -135.663% |
| PAVmed Inc | -64.17 Million USD | 82.929% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 79.12% |
| RxSight, Inc. | -48.6 Million USD | 77.462% |
| Sight Sciences, Inc. | -55.54 Million USD | 80.277% |
| SI-BONE, Inc. | -43.33 Million USD | 74.72% |
| TELA Bio, Inc. | -46.66 Million USD | 76.523% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 81.444% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 77.88% |
| LivaNova PLC | 17.54 Million USD | 162.438% |
| 908 Devices Inc. | -36.39 Million USD | 69.902% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 94.13% |
| Nemaura Medical Inc. | -14.14 Million USD | 22.543% |
| NeuroPace, Inc. | -32.95 Million USD | 66.758% |
| LENSAR, Inc. | -14.38 Million USD | 23.832% |
| Apyx Medical Corporation | -18.71 Million USD | 41.456% |
| Cutera, Inc. | -162.83 Million USD | 93.272% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -1.157% |
| BioSig Technologies, Inc. | -29.04 Million USD | 62.276% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 86.748% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 50.404% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 116.172% |
| Axonics, Inc. | -6.08 Million USD | -79.949% |
| Outset Medical, Inc. | -172.79 Million USD | 93.66% |
| IRIDEX Corporation | -9.57 Million USD | -14.475% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 89.655% |
| IRadimed Corporation | 17.19 Million USD | 163.72% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -32.888% |
| INVO Bioscience, Inc. | -8.03 Million USD | -36.351% |
| Telesis Bio, Inc. | -47.72 Million USD | 77.044% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 206.954% |
| Varex Imaging Corporation | -47.7 Million USD | 77.033% |
| Quipt Home Medical Corp. | -2.78 Million USD | -293.509% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 2.93% |
| Pulmonx Corporation | -60.84 Million USD | 81.994% |
| Dynatronics Corporation | -2.69 Million USD | -306.095% |
| Modular Medical, Inc. | -17.47 Million USD | 37.291% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 3.791% |
| Semler Scientific, Inc. | 20.58 Million USD | 153.225% |
| InMode Ltd. | 197.91 Million USD | 105.535% |
| Bruker Corporation | 427.2 Million USD | 102.564% |
| Cytosorbents Corporation | -28.5 Million USD | 61.57% |
| DexCom, Inc. | 541.5 Million USD | 102.023% |
| Align Technology, Inc. | 445.05 Million USD | 102.462% |
| Viveve Medical, Inc. | -22.02 Million USD | 50.264% |
| ZimVie Inc. | -393.28 Million USD | 97.214% |
| Movano Inc. | -29.28 Million USD | 62.588% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 9.818% |
| Nexalin Technology, Inc. | -4.64 Million USD | -135.663% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1811.241% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 95.079% |
| Profound Medical Corp. | -28.56 Million USD | 61.653% |
| Insulet Corporation | 206.3 Million USD | 105.31% |
| enVVeno Medical Corporation | -23.51 Million USD | 53.413% |
| Surmodics, Inc. | -11.54 Million USD | 5.083% |
| iCAD, Inc. | -4.84 Million USD | -126.022% |
| Nuwellis, Inc. | -20.2 Million USD | 45.79% |
| Biotricity, Inc. | -14.09 Million USD | 22.271% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 91.123% |
| Aethlon Medical, Inc. | -12.2 Million USD | 10.263% |
| InspireMD, Inc. | -19.91 Million USD | 44.992% |
| PAVmed Inc. | -64.17 Million USD | 82.929% |
| BIOLASE, Inc. | -20.63 Million USD | 46.901% |
| Beyond Air, Inc. | -60.24 Million USD | 81.815% |
| FONAR Corporation | 10.56 Million USD | 203.671% |
| AxoGen, Inc. | -21.71 Million USD | 49.552% |
| Vivani Medical, Inc. | -25.65 Million USD | 57.293% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 138.419% |
| Inari Medical, Inc. | -1.63 Million USD | -569.639% |
| UFP Technologies, Inc. | 44.92 Million USD | 124.386% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -113.456% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -65.858% |
| Tenon Medical, Inc. | -15.58 Million USD | 29.688% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 28.982% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 68.994% |
| AdaptHealth Corp. | -678.89 Million USD | 98.386% |
| Sintx Technologies, Inc. | -8.25 Million USD | -32.647% |
| NanoVibronix, Inc. | -3.71 Million USD | -195.211% |
| Quanterix Corporation | -32.33 Million USD | 66.118% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 2.93% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 2358.824% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.428% |
| TransMedics Group, Inc. | -25.02 Million USD | 56.228% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 50.502% |
| NeuroMetrix, Inc. | -6.52 Million USD | -67.782% |
| Hyperfine, Inc. | -44.23 Million USD | 75.236% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 86.045% |
| Biomerica, Inc. | -5.97 Million USD | -83.26% |
| Bone Biologics Corporation | -8.94 Million USD | -22.423% |
| AVITA Medical, Inc. | -39.16 Million USD | 72.03% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -10.06% |
| Silk Road Medical, Inc | -55.74 Million USD | 80.347% |